<DOC>
	<DOCNO>NCT01407341</DOCNO>
	<brief_summary>This pilot clinical trial study beta-tricalcium phosphate bone graft treat patient undergo surgery metastatic spine cancer . A bone graft may help heal bone growth patient undergo surgery spine cancer</brief_summary>
	<brief_title>Beta-Tricalcium Phosphate Bone Graft Treating Patients Undergoing Surgery For Metastatic Spine Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . To determine Chronos ( beta-tricalcium phosphate bone graft ) form posterolateral fusion mass patient undergoing fusion surgery spine cancer within 12 month . II . To evaluate quality life follow use ChronOS measured ( ) pain ( lack pain ) associate pseudoarthrosis ( b ) need additional treatment instability result hardware failure . OUTLINE : Patients undergo placement beta-tricalcium phosphate bone graft strip posterolaterally surgery . After completion study treatment , patient follow 1 month every 3 month 1 year .</detailed_description>
	<mesh_term>Spinal Cord Compression</mesh_term>
	<mesh_term>Spinal Cord Neoplasms</mesh_term>
	<criteria>All patient undergo surgery spinal decompression tatic spine cancer require bone substitute posterolateral spinal fusion Patients may may posterolateral instrumentation Statuspost previous fusion allogeneic bone graft</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>